News Daily News Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle Todd Neale September 12, 2023
News Daily News Hospital at Home Strategy Could Disrupt ‘Low-Value’ Care for Worsening HF L.A. McKeown September 07, 2023
News Conference News ESC 2023 ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran Michael O'Riordan September 01, 2023
News Daily News First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists L.A. McKeown August 31, 2023
News Conference News ESC 2023 New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground Caitlin E. Cox August 30, 2023
News Conference News ESC 2023 STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function Shelley Wood August 25, 2023
News Daily News High Troponin Signals Increased Mortality Risk in Broad Hospital Cohort Todd Neale August 10, 2023
News Daily News SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity Todd Neale August 08, 2023
News Daily News Women and Minorities Underrepresented in Heart Valve Trials L.A. McKeown July 27, 2023
News Daily News USPSTF: Screening Kids for Lipid Disorders Still Needs More Data Shelley Wood July 18, 2023
News Daily News SGLT2i May Be Helpful Early After Acute MI in Diabetic Patients Todd Neale July 17, 2023
News Daily News EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss Michael O'Riordan July 12, 2023
News Daily News Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death Michael O'Riordan July 07, 2023
News Conference News ADA 2023 Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1 Shelley Wood June 29, 2023
News Conference News ADA 2023 Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide L.A. McKeown June 28, 2023
News Conference News ADA 2023 Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention Michael O'Riordan June 28, 2023